List of works - Stephen Clarke

A Critical Assessment of Postneoadjuvant Therapy Pancreatic Cancer Regression Grading Schemes With a Proposal for a Novel Approach

scientific article published on 16 October 2020

A Longitudinal Investigation of Inflammatory Markers in Colorectal Cancer Patients Perioperatively Demonstrates Benefit in Serial Remeasurement

scientific article published on 7 April 2017

A Prospective Study of Circulating Tumor DNA to Guide Matched Targeted Therapy in Lung Cancers

scientific article published on 01 June 2019

A Significant Metabolic and Radiological Response after a Novel Targeted MicroRNA-based Treatment Approach in Malignant Pleural Mesothelioma.

scientific article

A critical review of the effects of medical Qigong on quality of life, immune function, and survival in cancer patients

scientific article published on 28 June 2011

A data-driven, knowledge-based approach to biomarker discovery: application to circulating microRNA markers of colorectal cancer prognosis.

scientific article

A multicenter study of thromboembolic events among patients diagnosed with ROS1-rearranged non-small cell lung cancer

scientific article published on 22 January 2020

A proteomics-based approach identifies secreted protein acidic and rich in cysteine as a prognostic biomarker in malignant pleural mesothelioma

scientific article published on 18 February 2016

A randomised controlled trial of an advance care planning intervention for patients with incurable cancer

scientific article published on 29 October 2018

A randomized controlled pilot trial comparing the impact of access to clinical endocrinology video demonstrations with access to usual revision resources on medical student performance of clinical endocrinology skills

scientific article

Activation of thermogenesis in brown adipose tissue and dysregulated lipid metabolism associated with cancer cachexia in mice.

scientific article published on 19 June 2012

Acupuncture in Oncology: The Effectiveness of Acupuncture May Not Depend on Needle Retention Duration.

scientific article published in October 2017

Adjuvant Iodine (131) Lipiodol after Resection of Hepatocellular Carcinoma

scientific article

Ado-Trastuzumab Emtansine for Patients With HER2-Mutant Lung Cancers: Results From a Phase II Basket Trial

scientific article published on 10 July 2018

Afatinib in patients with metastatic or recurrent HER2-mutant lung cancers: a retrospective international multicentre study

scientific article published on 24 January 2019

Altered cytochrome 2E1 and 3A P450-dependent drug metabolism in advanced ovarian cancer correlates to tumour-associated inflammation

scientific article published on 05 August 2019

An Australian translational study to evaluate the prognostic role of inflammatory markers in patients with metastatic ColorEctal caNcer Treated with bevacizumab (Avastin™) [ASCENT]

scientific article

An update on ethnic differences in drug metabolism and toxicity from anti-cancer drugs.

scientific article published on 28 September 2011

Analytical performance of nano-LC-SRM using nondepleted human plasma over an 18-month period

scientific article

Australian recommendations for EGFR T790M testing in advanced non-small cell lung cancer

scientific article

Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial

scientific article published on 16 November 2012

Beyond Conventional Cancer Treatments: "The Use of Complementary Therapies During Cancer Treatment: Implications for Clinicians"

Biomarker panel predicts survival after resection in pancreatic ductal adenocarcinoma: A multi-institutional cohort study

scientific article published on 11 October 2018

Cancer-Related Systemic Inflammation: The Challenges and Therapeutic Opportunities for Personalized Medicine

scientific article

Cancer-related inflammation and treatment effectiveness

scientific article published on October 2014

Capecitabine, bevacizumab, and mitomycin in first-line treatment of metastatic colorectal cancer: results of the Australasian Gastrointestinal Trials Group Randomized Phase III MAX Study

scientific article

Classification of cancer patients using pathway analysis and network clustering

scientific article published on 01 January 2011

Clinical development of TargomiRs, a miRNA mimic-based treatment for patients with recurrent thoracic cancer

scientific article published on 17 May 2016

Clinical pharmacology of chemotherapy agents in older people with cancer

scientific article

Clinical trial information as a measure of quality cancer care

scientific article

Cognitive Function in Patients With Colorectal Cancer Who Do and Do Not Receive Chemotherapy: A Prospective, Longitudinal, Controlled Study

scientific article published on 2 November 2015

Cognitive function and fatigue after diagnosis of colorectal cancer

scientific article

Colorectal cancer cell surface protein profiling using an antibody microarray and fluorescence multiplexing

scientific article published on 25 September 2011

Comment on 'Existing prognostic models, but not neutrophil-to-lymphocyte ratio, are prognostic in malignant mesothelioma'.

scientific article published on 8 April 2014

Complete response in a patient with stage IV adrenocortical carcinoma treated with adjuvant trans-catheter arterial chemo-embolization (TACE).

scientific article published on 6 September 2017

Correction to: The role of proteomics in the age of immunotherapies

scientific article published on 01 December 2018

Cyto-Immuno-Therapy for Cancer: A Pathway Elicited by Tumor-Targeted, Cytotoxic Drug-Packaged Bacterially Derived Nanocells

scientific article published on 01 March 2020

Dual Somatostatin Receptor/FDG PET/CT Imaging in Metastatic Neuroendocrine Tumours: Proposal for a Novel Grading Scheme with Prognostic Significance

scientific article

Eligibility of patients with advanced non-small cell lung cancer for phase III chemotherapy trials

scientific article

Enduring complete metabolic response in metastatic adenocarcinoma of the gastro-oesophageal junction

scientific article published on 3 September 2014

Estimating survival in advanced cancer: a comparison of estimates made by oncologists and patients

scientific article published on 28 November 2019

Ethnic differences in drug metabolism and toxicity from chemotherapy

article

Evaluation of Fluorodeoxyglucose Positron Emission Tomography Scanning in the Neoadjuvant Therapy Paradigm in Pancreatic Ductal Adenocarcinoma

scientific article published on 01 February 2020

Exhaled breath condensate for lung cancer protein analysis: a review of methods and biomarkers.

scientific article

Extrahepatic cancer suppresses nuclear receptor-regulated drug metabolism

scientific article

Factors affecting whether or not cancer patients consider using acupuncture

scientific article published on 22 September 2016

First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 tri

scientific article published on 03 August 2017

From mice to men: GEMMs as trial patients for new NSCLC therapies

scientific article published on March 2014

Glutathione S-transferase Pi expression predicts response to adjuvant chemotherapy for stage C colon cancer: a matched historical control study

scientific article

High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy.

scientific article published on 18 October 2010

High metabolic tumour volume on FDG PET predicts poor survival from neuroendocrine neoplasms

scientific article published on 12 November 2019

Immunohistochemical validation of overexpressed genes identified by global expression microarrays in adrenocortical carcinoma reveals potential predictive and prognostic biomarkers

scientific article

Impact of physical activity on fatigue and quality of life in people with advanced lung cancer: a randomized controlled trial

scientific article

Inflammatory (B) symptoms are independent predictors of myelosuppression from chemotherapy in Non-Hodgkin Lymphoma (NHL) patients--analysis of data from a British National Lymphoma Investigation phase III trial comparing CHOP to PMitCEBO.

scientific article

Influence of molecular classification in anaplastic glioma for determining outcome and future approach to management

scientific article published on 24 January 2019

Investigation of herb-drug interactions with ginkgo biloba in women receiving hormonal treatment for early breast cancer.

scientific article published on 22 March 2013

Journal Club

Low calretinin expression and high neutrophil-to-lymphocyte ratio are poor prognostic factors in patients with malignant mesothelioma undergoing extrapleural pneumonectomy.

scientific article published in November 2011

Mass Cytometry Reveals a Sustained Reduction in CD16+ Natural Killer Cells Following Chemotherapy in Colorectal Cancer Patients

scientific article published on 05 November 2019

Monitoring quality of care in hepatocellular carcinoma: A modified Delphi consensus

scholarly article

Mouse Model of Mutated in Colorectal Cancer Gene Deletion Reveals Novel Pathways in Inflammation and Cancer

article

Multicenter randomized, open-label phase II trial of sequential erlotinib and gemcitabine compared with gemcitabine monotherapy as first-line therapy in elderly or ECOG PS two patients with advanced NSCLC.

scientific article published on 27 February 2014

Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-Analysis

scientific article published on 01 August 2019

Neutrophil-to-lymphocyte ratio in head and neck cancer

scientific article published on 23 April 2015

Oral cannabinoid-rich THC/CBD cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting: a study protocol for a pilot and definitive randomised double-blind placebo-controlled trial (CannabisCINV)

scientific article published on 12 September 2018

Pharmacokinetics and pharmacodynamics of intraperitoneal cancer chemotherapeutics

scientific article published on April 2012

Pharmacometabonomic profiling as a predictor of toxicity in patients with inoperable colorectal cancer treated with capecitabine

scientific article published on 17 March 2011

Predictive markers for haematological toxicity of pemetrexed

scientific article published on January 2010

Preoperative neutrophil/lymphocyte ratio predicts overall survival but does not predict recurrence or cancer-specific survival after curative resection of node-positive colorectal cancer

scientific article

Primary Pericardial Sarcoma with Right Atrial Invasion and Multiple Bilateral Pulmonary Metastases in a Patient with Hereditary Nonpolyposis Colorectal Cancer.

scientific article

Randomized controlled trial of a structured intervention to facilitate end-of-life decision making in patients with advanced cancer

scientific article

Retrospective cohort analysis of neoadjuvant treatment and survival in resectable and borderline resectable pancreatic ductal adenocarcinoma in a high volume referral centre

scientific article

Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study.

scientific article published on September 2017

Selective Internal Radiation Therapy (SIRT) with yttrium-90 resin microspheres plus standard systemic chemotherapy regimen of FOLFOX versus FOLFOX alone as first-line treatment of non-resectable liver metastases from colorectal cancer: the SIRFLOX s

scientific article

Serum bicarbonate is a marker of peri-operative mortality but is not associated with long term survival in colorectal cancer

scientific article published on 30 January 2020

Somatostatin Receptor SSTR-2a Expression Is a Stronger Predictor for Survival Than Ki-67 in Pancreatic Neuroendocrine Tumors.

scientific article published on October 2015

Straddling medical specialties: should we have more comprehensive advanced training?

scientific article published on 01 May 2019

Streptavidin: a novel immunostimulant for the selection and delivery of autologous and syngeneic tumor vaccines

scientific article published on 21 February 2014

Supporting treatment decision making in advanced cancer: a randomized trial of a decision aid for patients with advanced colorectal cancer considering chemotherapy

scientific article published on 11 April 2011

Systematic Review of the Role of Targeted Therapy in Metastatic Neuroendocrine Tumors

scientific article published on 16 April 2016

Tailored first-line and second-line CDK4-targeting treatment combinations in mouse models of pancreatic cancer

scientific article published on 28 October 2017

Temporal and spatial modulation of the tumor and systemic immune response in the murine Gl261 glioma model

scientific article published on 02 April 2020

The Effects of Acupuncture on Cancer-Related Fatigue: Updated Systematic Review and Meta-Analysis

scientific article published on 01 January 2020

The Lymphocyte-to-Monocyte Ratio is a Superior Predictor of Overall Survival in Comparison to Established Biomarkers of Resectable Colorectal Cancer

scientific article published on 08 April 2016

The addition of anti-angiogenic tyrosine kinase inhibitors to chemotherapy for patients with advanced non-small-cell lung cancers: A meta-analysis of randomized trials

scientific article published on 17 October 2016

The impact of neutrophil-lymphocyte ratio on risk reclassification of patients with advanced renal cell cancer to guide risk-directed therapy

scientific article published on 29 August 2019

The impact of physical activity on fatigue and quality of life in lung cancer patients: a randomised controlled trial protocol

scientific article

The integration of pharmacology and pathophysiology into locoregional chemotherapy delivery via mass fluid transfer

scientific article published on 19 October 2018

The prognostic role of inflammatory markers in patients with metastatic colorectal cancer treated with bevacizumab: A translational study [ASCENT]

scientific article published on 06 March 2020

The role of adjuvant probiotics to attenuate intestinal inflammatory responses due to cancer treatments

scientific article published on 20 September 2018

The role of proteomics in the age of immunotherapies

scientific article published on 25 July 2018

The vermiform appendix: an immunological organ sustaining a microbiome inoculum

scientific article published on 03 January 2019

Treatment and management of adrenal cancer in a specialized Australian endocrine surgical unit: approaches, outcomes and lessons learnt

scientific article published on 01 January 2019

Treatment of ALK-rearranged non-small cell lung cancer: A review of the landscape and approach to emerging patterns of treatment resistance in the Australian context

scientific article published on August 2017

Tumor sidedness is not an independent prognostic marker of colorectal cancer patients undergoing curative resection: A retrospective cohort study

scientific article published on 12 June 2019

Validation of tissue microarray technology in malignant pleural mesothelioma.

scientific article published on February 2011

List of works by Stephen Clarke

A Critical Assessment of Postneoadjuvant Therapy Pancreatic Cancer Regression Grading Schemes With a Proposal for a Novel Approach

A Longitudinal Investigation of Inflammatory Markers in Colorectal Cancer Patients Perioperatively Demonstrates Benefit in Serial Remeasurement

A Prospective Study of Circulating Tumor DNA to Guide Matched Targeted Therapy in Lung Cancers

A Significant Metabolic and Radiological Response after a Novel Targeted MicroRNA-based Treatment Approach in Malignant Pleural Mesothelioma.

A critical review of the effects of medical Qigong on quality of life, immune function, and survival in cancer patients

A data-driven, knowledge-based approach to biomarker discovery: application to circulating microRNA markers of colorectal cancer prognosis.

A multicenter study of thromboembolic events among patients diagnosed with ROS1-rearranged non-small cell lung cancer

A proteomics-based approach identifies secreted protein acidic and rich in cysteine as a prognostic biomarker in malignant pleural mesothelioma

A randomised controlled trial of an advance care planning intervention for patients with incurable cancer

A randomized controlled pilot trial comparing the impact of access to clinical endocrinology video demonstrations with access to usual revision resources on medical student performance of clinical endocrinology skills

Activation of thermogenesis in brown adipose tissue and dysregulated lipid metabolism associated with cancer cachexia in mice.

Acupuncture in Oncology: The Effectiveness of Acupuncture May Not Depend on Needle Retention Duration.

Adjuvant Iodine (131) Lipiodol after Resection of Hepatocellular Carcinoma

Ado-Trastuzumab Emtansine for Patients With HER2-Mutant Lung Cancers: Results From a Phase II Basket Trial

Afatinib in patients with metastatic or recurrent HER2-mutant lung cancers: a retrospective international multicentre study

Altered cytochrome 2E1 and 3A P450-dependent drug metabolism in advanced ovarian cancer correlates to tumour-associated inflammation

An Australian translational study to evaluate the prognostic role of inflammatory markers in patients with metastatic ColorEctal caNcer Treated with bevacizumab (Avastin™) [ASCENT]

An update on ethnic differences in drug metabolism and toxicity from anti-cancer drugs.

Analytical performance of nano-LC-SRM using nondepleted human plasma over an 18-month period

Australian recommendations for EGFR T790M testing in advanced non-small cell lung cancer

Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial

Beyond Conventional Cancer Treatments: "The Use of Complementary Therapies During Cancer Treatment: Implications for Clinicians"

Biomarker panel predicts survival after resection in pancreatic ductal adenocarcinoma: A multi-institutional cohort study

Cancer-Related Systemic Inflammation: The Challenges and Therapeutic Opportunities for Personalized Medicine

Cancer-related inflammation and treatment effectiveness

Capecitabine, bevacizumab, and mitomycin in first-line treatment of metastatic colorectal cancer: results of the Australasian Gastrointestinal Trials Group Randomized Phase III MAX Study

Classification of cancer patients using pathway analysis and network clustering

Clinical development of TargomiRs, a miRNA mimic-based treatment for patients with recurrent thoracic cancer

Clinical pharmacology of chemotherapy agents in older people with cancer

Clinical trial information as a measure of quality cancer care

Cognitive Function in Patients With Colorectal Cancer Who Do and Do Not Receive Chemotherapy: A Prospective, Longitudinal, Controlled Study

Cognitive function and fatigue after diagnosis of colorectal cancer

Colorectal cancer cell surface protein profiling using an antibody microarray and fluorescence multiplexing

Comment on 'Existing prognostic models, but not neutrophil-to-lymphocyte ratio, are prognostic in malignant mesothelioma'.

Complete response in a patient with stage IV adrenocortical carcinoma treated with adjuvant trans-catheter arterial chemo-embolization (TACE).

Correction to: The role of proteomics in the age of immunotherapies

Cyto-Immuno-Therapy for Cancer: A Pathway Elicited by Tumor-Targeted, Cytotoxic Drug-Packaged Bacterially Derived Nanocells

Dual Somatostatin Receptor/FDG PET/CT Imaging in Metastatic Neuroendocrine Tumours: Proposal for a Novel Grading Scheme with Prognostic Significance

Eligibility of patients with advanced non-small cell lung cancer for phase III chemotherapy trials

Enduring complete metabolic response in metastatic adenocarcinoma of the gastro-oesophageal junction

Estimating survival in advanced cancer: a comparison of estimates made by oncologists and patients

Ethnic differences in drug metabolism and toxicity from chemotherapy

Evaluation of Fluorodeoxyglucose Positron Emission Tomography Scanning in the Neoadjuvant Therapy Paradigm in Pancreatic Ductal Adenocarcinoma

Exhaled breath condensate for lung cancer protein analysis: a review of methods and biomarkers.

Extrahepatic cancer suppresses nuclear receptor-regulated drug metabolism

Factors affecting whether or not cancer patients consider using acupuncture

First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 tri

From mice to men: GEMMs as trial patients for new NSCLC therapies

Glutathione S-transferase Pi expression predicts response to adjuvant chemotherapy for stage C colon cancer: a matched historical control study

High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy.

High metabolic tumour volume on FDG PET predicts poor survival from neuroendocrine neoplasms

Immunohistochemical validation of overexpressed genes identified by global expression microarrays in adrenocortical carcinoma reveals potential predictive and prognostic biomarkers

Impact of physical activity on fatigue and quality of life in people with advanced lung cancer: a randomized controlled trial

Inflammatory (B) symptoms are independent predictors of myelosuppression from chemotherapy in Non-Hodgkin Lymphoma (NHL) patients--analysis of data from a British National Lymphoma Investigation phase III trial comparing CHOP to PMitCEBO.

Influence of molecular classification in anaplastic glioma for determining outcome and future approach to management

Investigation of herb-drug interactions with ginkgo biloba in women receiving hormonal treatment for early breast cancer.

Journal Club

Low calretinin expression and high neutrophil-to-lymphocyte ratio are poor prognostic factors in patients with malignant mesothelioma undergoing extrapleural pneumonectomy.

Mass Cytometry Reveals a Sustained Reduction in CD16+ Natural Killer Cells Following Chemotherapy in Colorectal Cancer Patients

Monitoring quality of care in hepatocellular carcinoma: A modified Delphi consensus

Mouse Model of Mutated in Colorectal Cancer Gene Deletion Reveals Novel Pathways in Inflammation and Cancer

Multicenter randomized, open-label phase II trial of sequential erlotinib and gemcitabine compared with gemcitabine monotherapy as first-line therapy in elderly or ECOG PS two patients with advanced NSCLC.

Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-Analysis

Neutrophil-to-lymphocyte ratio in head and neck cancer

Oral cannabinoid-rich THC/CBD cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting: a study protocol for a pilot and definitive randomised double-blind placebo-controlled trial (CannabisCINV)

Pharmacokinetics and pharmacodynamics of intraperitoneal cancer chemotherapeutics

Pharmacometabonomic profiling as a predictor of toxicity in patients with inoperable colorectal cancer treated with capecitabine

Predictive markers for haematological toxicity of pemetrexed

Preoperative neutrophil/lymphocyte ratio predicts overall survival but does not predict recurrence or cancer-specific survival after curative resection of node-positive colorectal cancer

Primary Pericardial Sarcoma with Right Atrial Invasion and Multiple Bilateral Pulmonary Metastases in a Patient with Hereditary Nonpolyposis Colorectal Cancer.

Randomized controlled trial of a structured intervention to facilitate end-of-life decision making in patients with advanced cancer

Retrospective cohort analysis of neoadjuvant treatment and survival in resectable and borderline resectable pancreatic ductal adenocarcinoma in a high volume referral centre

Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study.

Selective Internal Radiation Therapy (SIRT) with yttrium-90 resin microspheres plus standard systemic chemotherapy regimen of FOLFOX versus FOLFOX alone as first-line treatment of non-resectable liver metastases from colorectal cancer: the SIRFLOX s

Serum bicarbonate is a marker of peri-operative mortality but is not associated with long term survival in colorectal cancer

Somatostatin Receptor SSTR-2a Expression Is a Stronger Predictor for Survival Than Ki-67 in Pancreatic Neuroendocrine Tumors.

Straddling medical specialties: should we have more comprehensive advanced training?

Streptavidin: a novel immunostimulant for the selection and delivery of autologous and syngeneic tumor vaccines

Supporting treatment decision making in advanced cancer: a randomized trial of a decision aid for patients with advanced colorectal cancer considering chemotherapy